🇺🇸 Dextrose infusion in United States

37 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 7 reports (18.92%)
  2. Hypotension — 5 reports (13.51%)
  3. Pyrexia — 5 reports (13.51%)
  4. General Physical Health Deterioration — 3 reports (8.11%)
  5. Infusion Related Reaction — 3 reports (8.11%)
  6. Pneumonia — 3 reports (8.11%)
  7. Respiratory Distress — 3 reports (8.11%)
  8. Septic Shock — 3 reports (8.11%)
  9. Vomiting — 3 reports (8.11%)
  10. Acute Myocardial Infarction — 2 reports (5.41%)

Source database →

Dextrose infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dextrose infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dextrose infusion in United States?

Wanpen Vongpatanasin is the originator. The local marketing authorisation holder may differ — check the official source linked above.